-
Signature
-
/s/ Elizabeth Feeney, Attorney-In-Fact
-
Issuer symbol
-
INCY
-
Transactions as of
-
19 Feb 2026
-
Net transactions value
-
-$734,086
-
Form type
-
4
-
Filing time
-
23 Feb 2026, 16:05:14 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| CAGNONI PABLO J |
President, R&D |
1801 AUGUSTINE CUT-OFF, WILMINGTON |
/s/ Elizabeth Feeney, Attorney-In-Fact |
23 Feb 2026 |
0001205703 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
INCY |
Common Stock |
Options Exercise |
$808,624 |
+13,093 |
+5.6% |
$61.76 |
247,893 |
19 Feb 2026 |
Direct |
|
| transaction |
INCY |
Common Stock |
Options Exercise |
$341,078 |
+5,575 |
+2.2% |
$61.18 |
253,468 |
19 Feb 2026 |
Direct |
|
| transaction |
INCY |
Common Stock |
Sale |
$1,883,788 |
-18,668 |
-7.4% |
$100.91 |
234,800 |
19 Feb 2026 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
INCY |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-13,093 |
-65% |
$0.000000 |
7,182 |
19 Feb 2026 |
Common Stock |
13,093 |
$61.76 |
Direct |
F2 |
| transaction |
INCY |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-5,575 |
-26% |
$0.000000 |
16,268 |
19 Feb 2026 |
Common Stock |
5,575 |
$61.18 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: